{
    "nct_id": "NCT06802172",
    "official_title": "Effect of Meal Timing During Cancer Treatment in Alaska Native Patients: a Randomized Clinical Trial",
    "inclusion_criteria": "* Male or female\n* Self-identify as Alaska Native or American Indian person and eligible for care at the Alaska Native Medical Center\n* Age ≥ 21 years\n* Histologically confirmed rectal cancer stage II or III per AJCC criteria\n* BMI≥18.5 kg/m2\n* Plan to receive either neoadjuvant conventional chemoradiation or total neoadjuvant therapy (TNT) with 5-fluorouracil-based regimens\n* Demonstrate adequate organ and marrow function within two weeks of study treatment initiation\n* Must have capacity to give informed consent\n* Willing and able to adhere to the assessments, visit schedules, prohibitions, and restrictions\nHealthy volunteers allowed\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* Prior neoadjuvant or adjuvant chemotherapy/radiation <12 months prior to rectal cancer occurrence\n* Allergic reaction to any of the treatment agents\n* Any prior pelvic radiotherapy or chemoradiotherapy\n* Major surgery/open biopsy ≤4 weeks prior to enrollment or minor surgery/core biopsy ≤1 week prior to enrollment\n* Currently active second malignancy other than non-melanoma skin cancers or cervical carcinoma in situ\n* History of GI perforation ≤12 months prior to enrollment\n* History of malabsorption, uncontrolled vomiting or diarrhea, or other GI-function affecting disease\n* History of predisposing colonic or small bowel disorders with uncontrolled symptoms\n* Receiving any parenteral nutrition or enteral (tube) feeding or using any other nutritional supplement during the study period\n* History of uncontrolled CHF defined as NYHA Class III or greater\n* Uncontrolled hypertension\n* History of bleeding events, bleeding diathesis, arterial thrombotic events (including TIA, CVA, unstable angina requiring intervention, or MI), or clinically significant PAD and ≤6 months prior to enrollment\n* Pre-existing grade ≥3 neuropathy\n* Currently participating in or has participated in a study of an investigational agent or investigational device ≤4 weeks of the first dose of treatment\n* Unstable psychiatric, sleep, or circadian conditions (common conditions such as sleep apnea and depression are acceptable as long as they are stabilized and not rapidly worsening)\n* Pregnant or breastfeeding\n* Currently perform overnight shift work more than one day/week on average\n* Regularly eat within an <11-hour period each day\n* Known psychiatric or substance misuse disorders that would interfere with adhering to the requirements of the trial\n* History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the participant's participation in the trial, or is not in the best interest of the participant to participate, in the opinions of the treating investigator.",
    "miscellaneous_criteria": ""
}